Report Library
All ReportsDatamonitor Key Trends in European Market Access
February 29, 2016
Datamonitor's independent research and analysis
provides extensive coverage of major disease areas, companies and strategic issues,
giving you the perspective to identify opportunities and threats arising from shifting market dynamics and the insights to
respond with faster, more effective decision-making. This strategy report focuses on Key Trends in European Market Access including
accelerating access to medicines, health technology assessment and harmonization, developments in health technology assessment,
pricing, and reimbursement delays.
Highlights
For more information on Datamonitor strategy reports, please email BioMedTracker or call BioMedTracker Client Services at (858) 200-2357.
For our disclosures, please read the BioMedTracker Research Standards.
Highlights
- Earlier access to medicines is a priority for the EU and its member states.
- France: the increasing importance of health economic evaluation.
- Germany: industry dissatisfaction with AMNOG continues.
- Italy: national and regional governments re-affirm commitment to HTA.
- Spain: therapeutic positioning reports have yet to streamline HTA processes.
- UK: NICE advocates limited methodological change, but establishes a new Office for Market Access and will play a key role in the Cancer Drugs Fund.
- External referencing pricing is common in Europe, but systems vary widely.
- Pricing and reimbursement delays pose a persistent problem for drug manufacturers, patients, and politicians.
- Manufacturers seek to minimize the impact of ERP by careful launch sequencing, offering discounts, or even withdrawing drugs in some circumstances.
- Industry calls for more moderate use of ERP are likely to have limited success.
For more information on Datamonitor strategy reports, please email BioMedTracker or call BioMedTracker Client Services at (858) 200-2357.
For our disclosures, please read the BioMedTracker Research Standards.
Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |
Additional Resources: